Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00878189 · ClinicalTrials.gov registry record · Phase 1
A Trial In Patients With Advanced Cancer And Leukemia
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 72
- Enrollment target
NCT00878189 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 72 participants.
The verdict
NCT00878189, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 72 participants
- Enrollment target
Study Summary
This is a phase 1, dose escalating study to determine the safety of PF-03084014 in patients with advanced cancer and leukemia
Interventions
- DRUG PF-03084014
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2009-06-25 |
| Est. Completion | 2016-11-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00878189
The ClinicalTrials.gov registry entry for NCT00878189 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PF-03084014 is the first listed.
NCT00878189 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00878189 about?
NCT00878189 is a clinical study titled "A Trial In Patients With Advanced Cancer And Leukemia". This is a phase 1, dose escalating study to determine the safety of PF-03084014 in patients with advanced cancer and leukemia
What is the current status of trial NCT00878189?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2009-06-25. Estimated completion is 2016-11-22.
What interventions are being tested in trial NCT00878189?
The interventions under investigation include: PF-03084014 (DRUG).
Who is sponsoring clinical trial NCT00878189?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.